clinical utility of the homologous recombination deficiency score in aml & mds
Published 1 year ago • 95 plays • Length 5:33Download video MP4
Download video MP3
Similar videos
-
3:46
introduction to homologous recombination deficiency (hrd) assessment
-
1:41
an overview of the mds diagnosis pathway
-
3:11
clinical characteristics of h-mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
5:38
the molecular and clinical classifications of mds
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
1:30
the prognostic value of patient-reported outcomes in mds
-
11:24
dna double strand breaks and repair systems part 2
-
4:34
the genetics of acute myeloid leukemia (aml)
-
7:18
response rate on phase 1/2 trial regn5458 (bcmaxcd3 bispecific antibody) for rrmm patients
-
3:01
challenges in distinguishing between pre-mds states and mds, and approaches to improve diagnosis
-
3:10
the role of ngs in mds diagnosis
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
1:17
common germline mutations in myelodysplastic syndromes
-
3:28
what are the different characteristics of homologous recombination deficiency (hrd) tests?
-
10:18
classification of high-risk mutations in mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:18
incorporating genetic analyses in the diagnostic pathway of mds
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
1:10
addressing leukemic transformation in mds: ongoing challenges and future outlooks
-
6:45
novel scoring system defines allo-hsct patients at high risk for cmv